JUAN FRANCISCO
DELGADO JIMÉNEZ
Catedrático de universidad
Imperial College London
Londres, Reino UnidoImperial College London-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2022
-
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
The Lancet Diabetes and Endocrinology, Vol. 10, Núm. 1, pp. 35-45
2020
-
Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5
Heart Rhythm, Vol. 17, Núm. 6, pp. 945-954